1. Home
  2. NEN vs ARMP Comparison

NEN vs ARMP Comparison

Compare NEN & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

NEN

New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

N/A

Current Price

$44.00

Market Cap

197.0M

Sector

Real Estate

ML Signal

N/A

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

N/A

Current Price

$3.72

Market Cap

199.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEN
ARMP
Founded
1977
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.0M
199.7M
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
NEN
ARMP
Price
$44.00
$3.72
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $17.50
AVG Volume (30 Days)
1.2K
★ 75.1K
Earning Date
11-13-2026
11-12-2026
Dividend Yield
★ 3.61%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $89,196,544.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.68
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$44.24
$2.75
52 Week High
$71.07
$14.98

Technical Indicators

Market Signals
Indicator
NEN
ARMP
Relative Strength Index (RSI) 32.93 55.78
Support Level N/A $3.38
Resistance Level $66.30 $3.96
Average True Range (ATR) 0.63 0.36
MACD -0.06 0.11
Stochastic Oscillator 0.00 93.64

Price Performance

Historical Comparison
NEN
ARMP

About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating, and selling real estate. The Partnership owns and operates various residential apartments, condominium units, and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent, and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: